Hi-Clearance Inc. (TPEX:1788)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
143.50
+0.50 (0.35%)
May 29, 2025, 1:30 PM CST
1.06%
Market Cap 6.39B
Revenue (ttm) 4.16B
Net Income (ttm) 348.16M
Shares Out 44.52M
EPS (ttm) 7.81
PE Ratio 18.37
Forward PE n/a
Dividend 7.00 (4.88%)
Ex-Dividend Date Jun 14, 2024
Volume 16,091
Average Volume 10,260
Open 144.00
Previous Close 143.50
Day's Range 143.00 - 144.00
52-Week Range 130.00 - 147.00
Beta 0.18
RSI 54.07
Earnings Date May 9, 2025

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and servi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1989
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1788
Full Company Profile

Financial Performance

In 2024, Hi-Clearance's revenue was 4.07 billion, an increase of 4.54% compared to the previous year's 3.90 billion. Earnings were 359.69 million, an increase of 3.36%.

Financial Statements

News

There is no news available yet.